The role of histamine H4 receptors as a potential targets in allergic rhinitis and asthma
Eva Hanuskova, Jana Plevkova
DOI: 10.4236/ojmip.2013.31002   PDF   HTML   XML   8,850 Downloads   14,588 Views   Citations


Histamine—the main product of mast cells plays critical role in the pathogenetic pathways of both allergic rhinitis and asthma. The novel concept of the unique airway diseases its only supported by the similarities within pathogenetic process. Antagonists of H1 and H2 receptors are quite effective in allergic rhinitis, but not effective enough in asthma. In an era of corticosteroids, leucotriene antagonists and Anti-IgE treatment, there is still a challenge to search for more effective, more acurate and more safe treatment option. Antagonists (inversive agonists) of histamine receptors H4 seems to be one of the promising targets in the allergic rhinitis and asthma treatment. The first H4 antagonist entered to clinics and the results from a proof-of-concept Phase II clinical study is expected to be disclosed soon. This review article summarizes current knowledge on H4R that have been collected in various studies sharing evidences about efficacy of H4R as a reasonable target for diseases with histamine involved pathogenetic pathways.

Share and Cite:

Hanuskova, E. and Plevkova, J. (2013) The role of histamine H4 receptors as a potential targets in allergic rhinitis and asthma. Open Journal of Molecular and Integrative Physiology, 3, 6-14. doi: 10.4236/ojmip.2013.31002.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Togias, A. (2001) Systemic cross-talk between the lung and the nose. American journal of respiratory and critical care medicine, 164, 726-727.
[2] Susiva, C. (2009) Antihistamine: Anti-allergic effects. Siriraj Medical Journal, 61, 66-67.
[3] Lewis, T. and Grant, T. (1924) Vascular reactions of the skin to injury. Heart, 11, 209-265.
[4] Popielski, L. (1920) β-Imidazolylathylamin und die Organextrakte Erster Teil: β-Imidazolylathylamin mechtiger Errezer der Magendrucken. Pfluegers Archiv, 178, 214-236. doi:10.1007/BF01722024
[5] Steinhoff, M., Griffiths, C., Church, M. and Lugar, T.A. (2004) Histamine. In: Burns, T., Breathnach, S., Cox, N. and Griffiths, C., Ed., Rook’s Textbook of Dermatology, Blackwell Science, Oxford, 9, 50-52.
[6] Endo, Y. (1982) Simultaneous induction of histidine and ornithine decarboxylases and changes in their product amines following the injection of Escherichia coli lipopolysaccharide into mice. Biochemical Pharmacology, 31, 1643-1647. doi:10.1016/0006-2952(82)90394-X
[7] Maintz, L. and Novak. N. (2007) Histamine and histamine intolerance. The American Journal of Clinical Nutrition, 85, 1185-1196.
[8] Saxena, S.P., Brandes, L.J., Becker, A.B., Simons, K.J., LaBella, F.S. and Gerrard, J.M. (1989) Histamine is an intracellular messenger mediating platelet aggregation. Science, 243, 1596-1599. doi:10.1126/science.2928797
[9] Shiraishi, M., Hirasawa, N., Oikawa, S., Kobayashi, Y. and Ohuchi, K. (2000) Analysis of histamine-producing cells at the late phase of allergic inflammation in rats. Immunology, 99, 600-606. doi:10.1046/j.1365-2567.2000.00986.x
[10] Szeberenyi, J.B, Pallinger, E., Zsinko, M., Pos, Z., Rothe, G., Orso, E., Szeberenyi, S., Schmitz, G., Falus, A. and Laszlo, V. (2001) Inhibition of effects of endogenously synthesized histamine disturbs in vitro human dendritic cell differentiation. Immunology Letters, 76, 175-182. doi:10.1016/S0165-2478(01)00184-5
[11] Vlieg-Boerstra, B.J., van der Heide, S., Oude Elberink, J.N., Kluin-Nelemans, J.C. and Dubois, A.E. (2005) Mastocytosis and adverse reactions to biogenic amines and histamine-releasing foods: What is the evidence? The Netherlands Journal of Medicine, 63, 244-249.
[12] Ring, J. (2004) Angewandte allergologie. Urban & Vogel, Munich.
[13] White, M.V., Slater, J. and Kaliner, M. (1987) Histamine and asthma. The American Review of Respiratory Disease, 57, 1165-1176.
[14] Nakamura, T., Itadani, H., Hidaka, Y., Ohta, M. and Tanaka, K. (2000) Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochemical and Biophysical Research Communications, 279, 615-620. doi:10.1006/bbrc.2000.4008
[15] Milligan, G., Bond, R. and Lee, M. (1995) Inverse agonism: Pharmacological curiosity or potential therapeutic strategy? Trends in Pharmacological Sciences, 16, 10-13. doi:10.1016/S0165-6147(00)88963-4
[16] Ash, A.S. and Schild, H.O. (1997) Receptors mediating some actions of histamine. 1966. British Journal of Pharmacology, 120, 302-314. doi:10.1111/j.1476-5381.1997.tb06811.x
[17] Thurmond, R.L, Desai, P.J., Dunford, P.J., et al. (2004) A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. The Journal of Pharmacology and Experimental Therapeutics, 309, 404-413. doi:10.1124/jpet.103.061754
[18] Jutel, M., Akdis, M. and Akdis, C.A. (2009) Histamine, histamine receptors and their role in immune pathology. Clinical & Experimental Allergy, 39, 1786-1800. doi:10.1111/j.1365-2222.2009.03374.x
[19] LaBella, F.S., Queen, G.M. and Brandes, L.J. (2000) Interactive binding at cytochrome P-450 of cell growth regulatory bioamines, steroid hormones, antihormones, and drugs. Journal of Cellular Biochemistry, 76, 686-694. doi:10.1002/(SICI)1097-4644(20000315)76:4<686::AID-JCB16>3.0.CO;2-V
[20] Brandes, L.J., Queen, G.M. and LaBella, F.S. (2000) N,N-diethyl-2-[4phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: Interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs. Cancer Chemotherapy and Pharmacology, 45, 298-304. doi:10.1007/s002800050044
[21] Paesen, G.C., Adams, P.L., Harlos, K., Nuttall, P.A. and Stuart, D.I. (1999) Tick histamine-binding proteins: Isolation, cloning, and three-dimensional structure. Molecular cell, 3, 661-671. doi:10.1016/S1097-2765(00)80359-7
[22] Raithel, M., Ulrich, P., Hochberger, J. and Hahn, E.G. (1998) Measurement of gut diamine oxidase activity. Diamine oxidase as a new biologic marker of colorectal proliferation? Annals of the New York Academy of Sciences, 859, 262-266. doi:10.1111/j.1749-6632.1998.tb11142.x
[23] Kusche, J., Bieganski, T., Hesterberg, R., Stahlknecht, C.D., Feussner, K.D., Stahlenberg, I. and Lorenz, W. (1980) The influence of carcinoma growth on diamine oxidase activity in human gastrointestinal tract. Agents and Actions, 10, 110-113. doi:10.1007/BF02024191
[24] Kalchmair, B., Klocker, J., Perkmann, R., Biebl, M., Bodner, G., Kolbitsch, C., Fraedrich, G. and Schwelberger, H.G. (2003) Alterations in plasma amine oxidase activities in a compartment syndrome model. Inflammation Research, 52, 67-68. doi:10.1007/s000110300058
[25] Maslinski, C. and Fogel, W.A. (1991) Catabolism of histamine. In: Uvn?s, B., Ed., Handbook of Experimental Pharmacology. Histamine and Histamine Antagonists. Springer, Berlin, 97, 165-189. doi:10.1007/978-3-642-75840-9_14
[26] Schwelberger, H.G., Hittmair, A. and Kohlwein, S.D. (1998) Analysis of tissue and subcellular localization of mammalian diamine oxidase by confocal laser scanning fluorescence microscopy. Inflamatory Research, 47, 6061. doi:10.1007/s000110050273
[27] Hill, S.J., Ganellin, C.R., Timmerman, H., Schwartz, J.C., Shankley, N.P., Young, J.M., Schunack, W., Levi, R. and Haas, H.L. (1997) International union of pharmacology. XIII. Classification of histamine receptors. Pharmacological reviews, 49, 253-278.
[28] Ikawa, Y., Suzuki, M., Shiono, S., Ohki, E., Moriya, H., Negishi, E. and Ueno, K. (2005) Histamine H4 receptor expression in human synovial cells obtained from patients suffering from rheumatoid arthritis. Biological & Pharmaceutical Bulletin, 28, 2016-2018. doi:10.1248/bpb.28.2016
[29] Dunford, P.J., O’Donnell, N., Riley, J.P., Williams, K.N., Karlsson, L. and Thurmond, R.L. (2006). The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+ T cells. The Journal of immunology, 176, 7062-7070. doi:10.1006/bbrc.2001.4976
[30] Cogé, F., Guénin, S.P., Rique, H., Boutin, J.A. and Galizzi, J.P. (2001) Structure and expression of the human histamine H4-receptor gene. Biochemical and Biophysical Research Communications, 284, 301-309.
[31] Gantner, F., Sakai, K., Tusche, M.W., Cruikshank, W.W., Center, D.M. and Bacon, K.B. (2002) Histamine H4 and H2 receptors control histamine-induced interleukin-16 release from human CD8+ T cells. The Journal of Pharmacology and Experimental Therapeutics, 303, 300-307. doi:10.1124/jpet.102.036939
[32] Gutzmer, R., Diestel, C., Mommert, S., K?ther, B., Stark, H., Wittmann, M. and Werfel, T. (2005) Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells. The Journal of immunology, 174, 5224-5232.
[33] Kakavas, S., Zampeli, E., Papamichael, K., Delitheos, B. and Tiligada, E. (2006) The mast cell pathway to inflammation and homeostasis: Pharma-cological insights. Current medicinal chemistry. Anti-Inflammatory & AntiAllergy Agents, 5, 323-334. doi:10.2174/187152306778772793
[34] Dunford, P.J., Williams, K.N., Desai, P.J., Karlsson, L., McQueen, D. and Thurmond, R.L. (2007) Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. The Journal of Allergy and Clinical Immunology, 119, 176183. doi:10.1016/j.jaci.2006.08.034
[35] Zhang, M., Thurmond, R.L. and Dunford, P.J. (2007) The histamine H4 receptor: A novel modulator of inflammatory and immune disorders. Pharmacology & Therapeutics, 113, 594-606. doi:10.1016/j.pharmthera.2006.11.008
[36] Oda, T., Morikawa, N., Saito, Y., Masuho, Y. and Matsumoto, S. (2000) Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. The Journal of Biological Chemistry, 275, 36781-36786. doi:10.1074/jbc.M006480200
[37] Zhu, Y., Michalovich, D., Wu, H., et al. (2001) Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Molecular Pharmacology, 59, 434-441.
[38] Nguyen, T., Shapiro, D.A., George, S.R., Setola, V., Lee, D.K., Cheng, R., Rauser, L., Lee, S.P., Lynch, K.R., Roth, B.L. and O’Dowd, B.F. (2001) Discovery of a novel member of the histamine receptor family. Molecular Pharmacology, 59, 427-433.
[39] Morse, K.L., Behan, J., Laz, T.M., et al. (2001) Cloning and characterization of a novel human histamine receptor. The Journal of Pharmacology and Experimental Therapeutics, 296, 1058-1066.
[40] Liu, C., Ma, X., Jiang, X., Wilson, S.J., Hofstra, C.L., Blevitt, J., Pyati, J., Li, X., Chai, W., Carruthers, N. and Lovenberg, T.W. (2001) Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow. Molecular Pharmacology, 59, 420-426.
[41] O’Reilly, M.R., Alpert, S., Jenkinson, R.P., et al. (2002) Identification of a histamine H4 receptor on human eosinophils: Role in eosinophil chemotaxis. Journal of Receptor and Signal Transduction Research, 22, 431448. doi:10.1081/RRS-120014612
[42] Cogé, F., Guénin, S.P., Audinot, V., Renouard-Try, A., Beauverger, P. and Macia, C. (2001) Genomic organization and characterization of splice variants of the human histamine H3 receptor. The Biochemical Journal, 355, 279-288. doi:10.1042/0264-6021:3550279
[43] Liu, C., Wilson, S.J., Kuei, C. and Lovenberg, T.W. (2001) Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation. The Journal of Pharmacology and Experimental Therapeutics, 299, 121-130.
[44] Oda, T., Matsumoto, S., Masuho, Y., Takasaki, J., Matsumoto, M., Kamohara, M., Saito, T., Ohishi, T., Soga, T., Hiyama, H., Matsushime, H. and Furuichi, K. cDNA cloning and characterization of porcine histamine H4 receptor. Biochimica et Biophysica Acta, 1575, 135138.
[45] Leurs, R., Chazot, P.L., Shenton, F.C., Lim, H.D. and de Esch, I.J. (2009) Molecular and biochemical pharmacology of the histamine H 4 receptor. British Journal of Pharmacology, 157, 14-23. doi:10.1111/j.1476-5381.2009.00250.x
[46] Buckland, K.F., Williams, T.J. and Conroy, D.M. (2003) Histamine induces cytoskeletal changes in human eosinophils via the H4 receptor. British Journal of Pharmacology, 140, 1117-1127. doi:10.1038/sj.bjp.0705530
[47] Hofstra, C.L., Desai, P.J., Thurmond, R.L. and FungLeung, W.P. (2003) Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. The Journal of Pharmacology and Experimental Therapeutics, 305, 1212-1221. doi:10.1124/jpet.102.046581
[48] De Esch, I.J., Thurmond, R.L., Jongejan, A. and Leurs, R. (2005) The histamine H4 receptor as a new therapeutic target for inflammation. Trends in Pharmacological Sciences, 26, 462-469.
[49] Rosethorne, E.M. and Charlton, S.J. (2011) Agonistbiased signaling at the histamine H4 receptor: JNJ7777120 recruits β-arrestin without activating G proteins. Molecular Pharmacology, 79, 749-757. doi:10.1124/mol.110.068395
[50] Seifert, R., Schneider, E.H, Dove, S., Brunskole, I., Neumann, D., Strasser, A. and Buschauer, A. (2011) Paradoxical stimulatory effects of the “standard” histamine H4 receptor antagonist JNJ7777120: The H4 receptor joins the club of 7 transmembrane domain receptors exhibiting functional selectivity. Molecular Pharmacology, 79, 631-638. doi:10.1124/mol.111.071266
[51] Schneider, E.H., Schnell, D., Papa, D. and Seifert, R. (2009) High constitutive activity and a Gproteinindependent high-affinity state of the human histamine H 4 receptor. Biochemistry, 48, 1424-1438. doi:10.1021/bi802050d
[52] Brunskole, I. (2011) Molecular and cellular analysis of aminergic G protein-coupled receptors: Histamine H2, H4 and β2-adrenergic receptors, a scientific paradigm. Dissertation, Universit?t Regensburg, Regensburg.
[53] Horr, B., Borck, H., Thurmond, R., Gr?sch, S. and Diel, F. (2006) STAT1 phosphorylation and cleavage is regulated by the histamine (H4) receptor in human atopic and non-atopic lymphocytes. International Immunopharmacology, 6, 1577-1585. doi:10.1016/j.intimp.2006.06.005
[54] Michel, I., Borck, H., McElligott, S., Krieg, C. and Diel, F. (2008) Histamine receptor H4R-selective ligands influence the STAT6 Transcription Activation Domain (TAD) and the DNA-binding. Inflammation Research, 57, 47-48. doi:10.1007/s00011-007-0623-1
[55] Godot, V., Arock, M., Garcia, G., Capel, F., Flys, C., Dy, M., Emilie, D. and Humbert, M. (2007) H4 histamine receptor mediates optimal migration of mast cell precursors to CXCL12. The Journal of Allergy and Clinical Immunology, 120, 827-834. doi:10.1016/j.jaci.2007.05.046
[56] Lippert, U., Artuc, M., Grützkau, A., Babina, M., Guhl, S., Haase, I., Blaschke, V., Zachmann, K., Knosalla, M., Middel, P., Krüger-Krasagakis, S. and Henz, B.M. (2004) Human skin mast cells express H2 and H4, but not H3 receptors. The Journal of Investigative Dermatology, 123, 116-123. doi:10.1111/j.0022-202X.2004.22721.x
[57] Barnard, R., Barnard, A., Salmon, G., Liu, W. and Sreckovic, S. (2008) Histamine-induced actin polymerization in human eosinophils: An imaging approach for histamine H4 receptor. Cytometry. Part A: The Journal of the International Society for Analytical Cytology, 73, 299-304.
[58] Damaj, B.B., Becerra, C.B., Esber, H.J., Wen, Y. and Maghazachi, A.A. (2007) Functional expression of H4 histamine receptor in human natural killer cells, monocytes, and dendritic cells. The Journal of Immunology, 179, 7907-7915.
[59] Ikawa, Y., Shiba, K., Ohki, E., Mutoh, N., Suzuki, M., Sato, H. and Ueno, K. (2008) Comparative study of histamine H4 receptor expression in human dermal fibroblasts. The Journal of Toxicological Sciences, 33, 503-508. doi:10.2131/jts.33.503
[60] Morini, G., Becchi, G., Shenton, F.C., Chazot, P.L. and Grandi, D. (2008) Histamine H3 and H4 receptors are expressed on distinct endocrine cell types in the rat fundic mucosa. Inflammation Research, 57, 57-58. doi:10.1007/s00011-007-0628-9
[61] Lim, H.D., Smits, R.A., Leurs, R. and De Esch, I.J. (2006) The emerging role of the histamine H4 receptor in antiinflammatory therapy. Current Topics in Medicinal Chemistry, 6, 1365-1373. doi:10.2174/15680266106061365
[62] Nakayama, T., Kato, Y., Hieshima, K., Nagakubo, D., Kunori, Y., Fujisawa, T. and Yoshie, O. (2004) Liverexpressed chemokine/CC chemokine ligand 16 attracts eosinophils by interacting with histamine H4 receptor. The Journal of Immunology, 173, 2078-2083.
[63] Ling, P., Ngo, K., Nguyen, S., Thurmond, R.L, Edwards, J.P., Karlsson, L. and Fung-Leung, W.P. (2004) Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. British Journal of Pharmacology, 142, 161-171. doi:10.1038/sj.bjp.0705729
[64] Takeshita, K., Sakai, K., Bacon, K.B. and Gantner, F. (2003) Critical role of histamine H4 receptor in leukotriene B4 production and mast cell-dependent neutrophil recruitment induced by zymosan in vivo. The Journal of Pharmacology and Experimental Therapeutics, 307, 1072-1078. doi:10.1124/jpet.103.057489
[65] Jutel, M., Watanabe, T., Klunker, S., Akdis, M., Thomet, O.A., Malolepszy, J., Zak-Nejmark, T., Koga, R., Kobayashi, T., Blaser, K. and Akdis, C.A. (2001) Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature, 413, 420425. doi:10.1038/35096564
[66] Dijkstra, D., Leurs, R., Chazot, P., Shenton, F.C., Stark, H., Werfel, T. and Gutzmer, R. (2007) Histamine downregulates monocyte CCL2 production through the histamine H4 receptor. The Journal of Allergy and Clinical Immunology, 120, 300-307. doi:10.1016/j.jaci.2007.03.024
[67] Dijkstra, D., Stark, H., Chazot, P.L., Shenton, F.C., Leurs, R., Werfel, T. and Gutzme, R. (2008). Human inflammatory dendritic epidermal cells express a functional histamine H 4 receptor. The Journal of Investigative Dermatology, 128, 1696-1703. doi:10.1038/sj.jid.5701250
[68] Busse, W.W. and Swenson, C.A. (1989) The relationship between plasma histamine concentrations and bronchial obstruction to antigen challenge in allergic rhinitis. The Journal of Allergy and Clinical Immunology, 84, 658666. doi:10.1016/0091-6749(89)90293-5
[69] Thurmond, R.L., Gelfand, E.W. and Dunford, P.J. (2008) The role of histamine H1 and H4 receptors in allergic inflammation: The search for new antihistamines. Nature Reviews. Drug Discovery, 7, 41-53. doi:10.1038/nrd2465
[70] Van Ganse, E., Kaufman, L., Derde, M.P., Yernault, J.C., Delaunois, L. and Vincken, W. (1997) Effects of antihistamines in adult asthma: A meta-analysis of clinical trials. The European Respiratory Journal, 10, 2216-2224. doi:10.1183/09031936.97.10102216
[71] Leopold, J.D., Hartley, J.P. and Smith, A.P. (1979) Effects of oral H1 and H2 receptor antagonists in asthma. The European Respiratory Journal, 8, 249-251.
[72] Neumann, D., Beermann, S. and Seifert, R. (2010) Does the histamine H4 receptor have a proor anti-inflammatory role in murine bronchial asthma? Pharmacology, 85, 217-223. doi:10.1159/000285088
[73] Yu, S., Stahl, E., Li, Q. and Ouyang, A. (2008) Antigen inhalation induces mast cells and eosinophils infiltration in the guinea pig esophageal epithelium involving histamine-mediated pathway. Life Sciences, 82, 324-330. doi:10.1016/j.lfs.2007.12.002
[74] Cowden, J.M., Riley, J.P., Ma, J.Y., Thurmond, R.L. and Dunford, P.J. (2010) Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokines. Respiratory Research, 11, 86. doi:10.1186/1465-9921-11-86
[75] Morgan, R.K., McAllister, B., Cross, L., Green, D.S., Kornfeld, H., Center, D.M. and Cruikshank, W.W. (2007) Histamine 4 receptor activation induces recruitment of FoxP3+ T cells and inhibits allergic asthma in a murine model. The Journal of immunology, 178, 8081-8089.
[76] Yu, F., Bonaventure, P. and Thurmond, R.L. (2010) The Future antihistamines: Histamine H(3) and H(4) receptor ligands, Advances in Experimental Medicine and Biology, 709, 125-140. doi:10.1007/978-1-4419-8056-4_12
[77] Deml, K.F., Beermann, S., Neumann, D., Strasser, A. and Seifert, R. (2009) Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4receptor. Molecular Pharmacology, 76, 1019-1030. doi:10.1124/mol.109.058651
[78] Pichavant, M., Matangkasombut, P., Dekruyff, R.H. and Umetsu, D.T. (2009) Natural killer T cells regulate the development of asthma. Expert Review of Clinical Immunology, 5, 251-260. doi:10.1586/eci.09.7
[79] Leite-de-Moraes, M.C., Diem, S., Michel, M.L., Ohtsu, H., Thurmond, R.L., Schneider, E. and Dy, M. (2009) Cutting edge: Histamine receptor H4 activation positively regulates in vivo IL-4 and IFN-gamma production by invariant NKT cells. The Journal of Immunology, 182, 1233-1236.
[80] Taylor-Clark, T.E. (2008) Insights into the mechanisms of histamine-induced inflammation in the nasal mucosa. Pulmonary Pharmacology & Therapeutics, 21, 455-460. doi:10.1016/j.pupt.2007.08.002
[81] Nakaya, M., Takeuchi, N. and Kondo, K. (2004) Immunohistochemical localization of histamine receptor subtypes in human inferior turbinates. The Annals of Otology, Rhinology, and Laryngology, 113, 552-557.
[82] Sugimoto, Y., Kawamoto, E., Chen, Z. and Kamei, C. (2000) A new model of allergic rhinitis in rats by topical sensitization and evaluation of H (1)-receptor antagonists. Immunopharmacology, 48, 1-7. doi:10.1016/S0162-3109(00)00173-9
[83] Howarth, P. (2002) Antihistamines in rhinoconjunctivitis. Clinical Allergy and Immunology, 17, 179-220.
[84] Takahashi, Y., Kagawa, Y., Izawa, K., Ono, R., Akagi, M. and Kamei, C. (2009) Effect of histamine H4 receptor antagonist on allergic rhinitis in mice. International Immunopharmacology, 9, 734-738. doi:10.1016/j.intimp.2009.02.011

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.